Bioinformatics Market Report Scope & Overview:

The Bioinformatics Market Size was valued at USD 11.58 billion in 2023 and is expected to reach USD 34.69 billion by 2031, and grow at a CAGR of 14.7% over the forecast period 2024-2031.

The introduction of user friendly and readily available bioinformatics software such as RasMol, AUTODOCK, BALL, Bioclipse in order to provide accurate and efficient analysis of discovery programs that contribute to detection of toxicity during the early stages of drug development is expected to drive the industry growth.

Bioinformatics Market Revenue Analysis

Get more information on Bioinformatics Market - Request Sample Report

Research conducted by Stanford scientists showed that a DNA sequencing technique could sequence a human genome in about eight hours, according to an article published by Stanford Medicine in January 2022. The demand for genomics and thus the bioinformatics sector can be stimulated by this development. To facilitate research activities in areas such as ageing and cancer, preventive therapy for genetic diseases, bioinformatics data storage and analysis applications are capable of storing a large amount of genomic and proteomic information. This factor is also expected to have a significant impact on the growth of this industry during the forecast period.



  • The popularity of personalised medicine is growing.

  • Spending on research and development in pharmaceuticals and biotechnology is increasing

  • Increasing funding from the public and private sectors for bioinformatics

In the field of bioinformatics, many governments and private organisations around the world are investing. Technological progress in the field of bioinformatics is a result of these investments, thereby improving the quality of this service. For instance, The European Molecular Biology Laboratory (EMBL), renowned for bioinformatics research, received funding from various organizations including the European Commission, Bill & Melinda Gates Foundation, and among others, for R&D in bioinformatics.


  • Professionals in Short Supply

  • Costs of Equipment is high

The need for quick and accurate bioinformatics tools that can be used easily has increased as a result of advances in NGS technology. Bioinformaticians are not necessarily scientists involved in experimental studies. Therefore, for the use of bioinformatics platforms there is a need to provide users with easily accessible user tools. A number of bioinformatics tools are in need of expert computer skills, particularly since they do not have an appropriate user-friendly interface.


  • The integration of machine learning and artificial intelligence (AI) into healthcare has already taken place

  • With the help of prominent IT companies, solutions are being developed in the field of bioinformatics

  • Opportunities for growth in emerging markets

Major players in the field of bioinformatics products and services have high growth opportunities in markets such as India, China, Brazil, Russia, Taiwan and South Korea. Major opportunities for growth in genomics, transcriptomics, personalised medicine, drug discovery and clinical diagnostics are expected to arise from the dominance of these emerging economies on research and development spending by global players over the coming years. In addition, because of the lower level of regulations and reduced data requirements, regulatory policies in the Asia Pacific region are more adaptive. Manufacturers will also be forced to focus on emerging markets because of the increasing competition in mature markets.


  • There is a lack of interoperability and multiplatform capacity.

  • Patient data confidentiality concerns

A large amount of biological data has been generated by the rapid adoption of next generation sequencing technologies, and with the rapid increase in data, the adoption of next generation sequencing technologies is growing. There is a need for data analysis because a lot of information is still missing from genome analysis. Therefore, data from the bioinformatics analysis process are very important and can be reused. The challenges of data management in bioinformatics are not adequately addressed by the existing solutions available on the market.

Impact of Russia-Ukraine War

Russia Ukraine war introduces a geopolitical dimension to global markets, including the area of Genomics Services. The impact depends on a number of factors, with the potential for positive and negative outcomes. Conflicts may interrupt the procurement of essential components, which could have a negative impact on operating continuity if genomics service providers are relying on supply chains that originate in those regions. Due to geopolitical tensions, international collaboration in the field of Genomics research may be hampered and could lead to a lack of exchange of knowledge and resources that are critical for progress on this issue.

Impact of Economic slowdown

Funding for bioinformatics research may be reduced in times of economic downturn, leading to a decreasing number of projects being funded. This has a negative impact on researchers' ability to carry out studies, recruit staff and acquire the required equipment. Infrastructure development, limitation of computational capacity and access to data are also affected by reduced financial support. In the end, these constraints slow down scientific progress and innovation in the field of bioinformatics. In addition, budget constraints may limit access to essential resources such as computing infrastructure or data repositories. In the case of bioinformatics, this limitation may impede research productivity and innovation.

Market Segmentation

By Product

  • Bioinformatics Platforms

    • Sequence Analysis Platforms

    • Sequence Manipulation Platforms

    • Sequence Alignment Platforms

    • Structural and Functional Analysis Platforms

    • Others

  • Bioinformatics Services

    • Sequencing

    • Database Management

    • Data Analysis

    • Others

  • Biocontent Management

  • Generalized Biocontent

  • Specialized Biocontent

The largest revenue share is expected to be accounted by the bioinformatics platforms segment over the forecast period. This is due to the increasing need for robust data management and analysis tools of omics data from genomics, proteomes or similar sources. Moreover, there are a number of data analysis techniques available on the bioinformatics platforms, such as data mining, sequencing and gene expression analyses. Moreover, these systems provide functions such as cloud-based data storage and visualisation that facilitate rapid access to large datasets and increase the collaboration of researchers.

By Application

  • Genomics

  • Molecular Phylogenetics

  • Metabolomics

  • Proteomics

  • Transcriptomics

  • Cheminformatics and drug designing

  • Others

The genomics segment accounted for a significant revenue share in 2023. Growing demand for pharmacogenomics in drug development and sequence screening and the introduction of technological advancements aimed at managing large sets of genomic data are key factors accounting for this large share. Also, due to an increasing need for analysis of genetic data in the fields of personalised medicine, drug discovery and disease diagnostics. The revenue growth of this segment is being driven by the availability of HTS technologies and decreasing costs for genome sequences.

Regional Analysis

In 2023, North America dominated the market with a revenue share of 43.9%. The large presence of top research organizations, academic institutions and bioinformatics companies in the region has led to a majority of revenues coming from the United States and Canada. The regional market is expected to be boosted by increased investments in research and development of new and innovative technologies related to molecular biology and genome sequencing. For example, in June 2022, LatchBio, California’s biotechnology research startup, launched an end-to-end bioinformatics platform that handles big biotech data to accelerate scientific discovery.

Asia Pacific is expected to be the most rapidly expanding region in the world with a CAGR of 18.4% over the forecast period. It is expected that the capacity to provide outsourcing services in advanced economies will be enhanced by the presence of skilled and experienced bioinformaticians, as well as a strongly developing information technology sector across the region. This region's growth is also projected to be driven by supportive government policies in the coming years.

For example, programs such as the China Precision Medicine Initiative and the China National Genebank, which focus on the use of bioinformatics in the field of genomics research and healthcare, have been launched in China. Similarly, programs have been put in place by countries such as India and South Korea to strengthen their bioinformatics capabilities and foster innovation in this area. The adoption and development of bioinformatics solutions is supported by government funding and aid.

Bioinformatics Market By Region

Need any customization research on Bioinformatics Market - Enquiry Now


North America

  • US

  • Canada

  • Mexico


  • Eastern Europe

    • Poland

    • Romania

    • Hungary

    • Turkey

    • Rest of Eastern Europe

  • Western Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Netherlands

    • Switzerland

    • Austria

    • Rest of Western Europe

Asia Pacific

  • China

  • India

  • Japan

  • South Korea

  • Vietnam

  • Singapore

  • Australia

  • Rest of Asia Pacific

Middle East & Africa

  • Middle East

    • UAE

    • Egypt

    • Saudi Arabia

    • Qatar

    • Rest of the Middle East

  • Africa

    • Nigeria

    • South Africa

    • Rest of Africa

Latin America

  • Brazil

  • Argentina

  • Colombia

  • Rest of Latin America


Some of the major key players of Bioinformatics Market are as follows: Affymetrix, BIOVIA, Agilent Technologies, BioWisdom Ltd, Celera Corporation, IBM, Life Sciences, Illumina Inc., Life Technologies Corporation, 3rd Millennium Inc, and other players.

Affymetrix-Company Financial Analysis

Company Landscape Analysis

Recent Developments:

  • In October 2022, by combining their strengths in AI based genome interpretation and analytical tools with industry's knowledge, Illumina, Inc. and AstraZeneca have set up a strategic research collaboration to accelerate the discovery of therapeutic targets. In order to identify potential treatments based on human omics insights, the cooperation will assess whether a framework made up of both technologies can enhance target discovery yields and confidence.

  • In September 2022, Thermo Fisher Scientific became a founding sponsor of the B+Labs incubator in Philadelphia and the Pennsylvania Biotechnology Center (PABC) in Doylestown, Pennsylvania. These initiatives aim to support emerging life science enterprises in accelerating their path to commercialization.

Bioinformatics Market Report Scope:
Report Attributes Details
Market Size in 2023 US$ 11.6 Billion
Market Size by 2031 US$ 32.6 Billion
CAGR CAGR of 13.8% From 2024 to 2031
Base Year 2023
Forecast Period 2024-2031
Historical Data 2020-2022
Report Scope & Coverage Market Size, Segments Analysis, Competitive  Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook
Key Segments • By Product (Bioinformatics Platforms, Bioinformatics Services, Biocontent Management)
• By Application (Genomics, Molecular Phylogenetics, Metabolomics, Proteomics, Transcriptomics, Cheminformatics and drug designing, Others)
Regional Analysis/Coverage North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America)
Company Profiles Affymetrix, BIOVIA, Agilent Technologies, BioWisdom Ltd, Celera Corporation, IBM, Life Sciences, Illumina Inc., Life Technologies Corporation, 3rd Millennium Inc, and other players.
DRIVERS • Growing bioinformatics financing from the public and private sectors
• Personalized medicine is becoming more popular.
• R&D spending on pharmaceuticals and biotechnology is increasing.
OPPORTUNITIES • Equipment expenditures are high.
• Professionals in Short Supply

Frequently Asked Questions

Ans: The Bioinformatics Market was valued at USD 11.58 billion in 2023.

Drivers, Restraints, Opportunities, and Challenges are the factors of marketing dynamics Bioinformatics market.

When it comes to giving critical support to various fields of scientific research, bioinformatics has always had tremendous potential. Bioinformatics was put to the test during the COVID-19 pandemic. During the COVID-19 pandemic, one of the key priority areas for each country was to research and understand ways to stop the virus's spread.

Yes, this report covers qualitative and quantitative analysis.

Ans: The expected CAGR of the global Bioinformatics Market during the forecast period is 14.7%.


1. Introduction

1.1 Market Definition

1.2 Scope

1.3 Research Assumptions

2. Industry Flowchart

3. Research Methodology

4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

5. Impact Analysis

5.1 Impact of Russia-Ukraine Crisis

5.2 Impact of Economic Slowdown on Major Countries

5.2.1 Introduction

5.2.2 United States

5.2.3 Canada

5.2.4 Germany

5.2.5 France

5.2.6 UK

5.2.7 China

5.2.8 Japan

5.2.9 South Korea

5.2.10 India

6. Value Chain Analysis

7. Porter’s 5 Forces Model

8.  Pest Analysis

9. Bioinformatics Market, By Product

9.1 Introduction

9.2 Trend Analysis

9.3 Bioinformatics Platforms

9.3.1 Sequence Analysis Platforms

9.3.2 Sequence Manipulation Platforms

9.3.3 Sequence Alignment Platforms

9.3.4 Structural and Functional Analysis Platforms

9.3.5 Others

9.4 Bioinformatics Services

9.4.1 Sequencing

9.4.2 Database Management

9.4.3 Data Analysis

9.4.4 Others

9.5 Biocontent Management

9.5.1 Generalized Biocontent

9.5.2 Specialized Biocontent

10. Bioinformatics Market, By Application

10.1 Introduction

10.2 Trend Analysis

10.3 Genomics

10.4 Molecular Phylogenetics

10.5 Metabolomics

10.6 Proteomics

10.7 Transcriptomics

10.8 Cheminformatics and drug designing

10.9 Others

11. Regional Analysis

11. Regional Analysis

11.1 Introduction

11.2 North America

11.2.1 USA

11.2.2 Canada

11.2.3 Mexico

11.3 Europe

11.3.1 Eastern Europe Poland Romania Hungary Turkey Rest of Eastern Europe

11.3.2 Western Europe Germany France UK Italy Spain Netherlands Switzerland Austria Rest of Western Europe

11.4 Asia-Pacific

11.4.1 China

11.4.2 India

11.4.3 Japan

11.4.4 South Korea

11.4.5 Vietnam

11.4.6 Singapore

11.4.7 Australia

11.4.8 Rest of Asia Pacific

11.5 The Middle East & Africa

11.5.1 Middle East UAE Egypt Saudi Arabia Qatar Rest of the Middle East

11.5.2 Africa Nigeria South Africa Rest of Africa

11.6 Latin America

11.6.1 Brazil

11.6.2 Argentina

11.6.3 Colombia

11.6.4 Rest of Latin America

12. Company Profiles

12.1 Affymetrix

12.1.1 Company Overview

12.1.2 Financial

12.1.3 Products/ Services Offered

12.1.4 SWOT Analysis

12.1.5 The SNS View


12.2.1 Company Overview

12.2.2 Financial

12.2.3 Products/ Services Offered

12.2.4 SWOT Analysis

12.2.5 The SNS View

12.3 Agilent Technologies

12.3.1 Company Overview

12.3.2 Financial

12.3.3 Products/ Services Offered

12.3.4 SWOT Analysis

12.3.5 The SNS View

12.4 BioWisdom Ltd

12.4.1 Company Overview

12.4.2 Financial

12.4.3 Products/ Services Offered

12.4.4 SWOT Analysis

12.4.5 The SNS View

12.5 Celera Corporation

12.5.1 Company Overview

12.5.2 Financial

12.5.3 Products/ Services Offered

12.5.4 SWOT Analysis

12.5.5 The SNS View

12.6 IBM

12.6.1 Company Overview

12.6.2 Financial

12.6.3 Products/ Services Offered

12.6.4 SWOT Analysis

12.6.5 The SNS View

12.7 Life Sciences

12.7.1 Company Overview

12.7.2 Financial

12.7.3 Products/ Services Offered

12.7.4 SWOT Analysis

12.7.5 The SNS View

12.8 Illumina Inc.

12.8.1 Company Overview

12.8.2 Financial

12.8.3 Products/ Services Offered

12.8.4 SWOT Analysis

12.8.5 The SNS View

12.9 Life Technologies Corporation

12.9.1 Company Overview

12.9.2 Financial

12.9.3 Products/ Services Offered

12.9.4 SWOT Analysis

12.9.5 The SNS View

12.10 3rd Millennium Inc

12.10.1 Company Overview

12.10.2 Financial

12.10.3 Products/ Services Offered

12.10.4 SWOT Analysis

12.10.5 The SNS View

13. Competitive Landscape

13.1 Competitive Benchmarking

13.2 Market Share Analysis

13.3 Recent Developments

13.3.1 Industry News

13.3.2 Company News

13.3.3 Mergers & Acquisitions

14. Use Case and Best Practices

15. Conclusion

An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.

Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.


The 5 steps process:

Step 1: Secondary Research:

Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.

Secondary Research

Step 2: Primary Research

When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data.  This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.

We at SNS Insider have divided Primary Research into 2 parts.

Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.

This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.

Primary Research

Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.

Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.

Step 3: Data Bank Validation

Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.

Data Bank Validation

Step 4: QA/QC Process

After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.

Step 5: Final QC/QA Process:

This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.

  •            5000 (33% Discount)

  •            8950 (40% Discount)

  •            3050 (23% Discount)

Start a Conversation

Hi! Click one of our member below to chat on Phone